Tumour suppressor genes: nature's defence against cancer

Robinson, Alex
August 1993
CMAJ: Canadian Medical Association Journal;8/1/1993, Vol. 149 Issue 3, p310
Academic Journal
No abstract available.


Related Articles

  • Tumour suppression: Putting on the brakes. Harris, Henry // Nature;1/15/2004, Vol. 427 Issue 6971, p201 

    This article focuses on the role oncogenes and tumor-suppressor genes play in tumor formation and tumor suppression. Viewing cancer as a disease of cell differentiation rather than multiplication, allows a redefinition of the role of onco genes and tumour-suppressor genes. It is often said that...

  • Tumour Suppressor Genes--One Hit Can Be Enough. Hohenstein, Peter // PLoS Biology;Feb2004, Vol. 2 Issue 2, p0165 

    Presents an article about cancer genetics and tumour suppressor genes. Information on oncogenes and its role in the development of cancer; Functions of tumour suppressor genes; Details of a paper published by Venkatachalam et, al. in the "EMBO Journal," which described a detailed study of...

  • Clinical image of the week.  // GP: General Practitioner;1/12/2004, p9 

    This article presents photograph of a tiny nematode worm which could help in the fight against breast cancer. Researchers from Cancer Research UK have found that the worm has a gene similar to the human BRCA1 tumour suppressor gene, that works in tandem with another gene, BARD1.

  • The null oncogene hypothesis and protection from cancer . Davenport, M.P.; Ward, R.L.; Hawkins, N.J. // Journal of Medical Genetics;Jan2002, Vol. 39 Issue 1, p12 

    Reports that tumour progression involves the inactivation of tumour suppressor genes and the activation of proto-oncogenes. How inactivation of both copies of a tumour suppressor gene is required for carcinogenesis, while germline deletion or inactivation of one copy results in an increase in...

  • Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Paige, A. J. W. // Cellular & Molecular Life Sciences;Oct2003, Vol. 60 Issue 10, p2147 

    Knudson’s two-hit model of tumour suppressor genes supposes that two mutations are required to cause a tumour, one occurring in each of the two alleles of the gene. Many such cancer genes exhibiting biallelic disruption and truncating point mutations have been identified, revealing the...

  • Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models. Grim, Jonathan E. // Gut;May2014, Vol. 63 Issue 5, p707 

    The author comments on the research study concerning on the cancer genomics which provides unprecedented views on solid tumors through mouse models. He outlines the characterization of colorectal cancer and the importance of oncogne and tumour suppressor pathways. He also adds the role of tumour...

  • Tumour suppressor gene mutations in humans and mice: parallels and contrasts. Hooper, Martin L. // EMBO Journal;12/1/98, Vol. 17 Issue 23, p6783 

    Tumour suppressor genes prevent cancer development. They can be identified by studying humans, but a full understanding of the mechanisms of their action requires the production of animal models. Mice with mutations in tumour suppressor genes can be produced by gene targeting. The phenotypic...

  • Tumour suppression: The burning issue of p63. Alderton, Gemma K. // Nature Reviews Cancer;Dec2010, Vol. 10 Issue 12, p814 

    The article discusses research being done on the function of p63 gene, a member of family p53, in promoting tumorigenesis and in suppression of tumour. It references the study "TAp63 supresses metastasis through coordinate regulation of Dicer and miRNAs," by X. Su and colleagues in the same...

  • DNA hypermethylation: when tumour suppressor genes go silent. Garinis, George A.; Patrinos, George P.; Spanakis, Nick E.; Menounos, Panayiotis G. // Human Genetics;Aug2002, Vol. 111 Issue 2, p115 

    The phenotype of the cancerous cell may arise either from genetic alterations that disrupt gene function through sequence modifications (mutations) or epigenetic events that may alter the heritable state of gene expression (i.e. without changing the actual sequence of the genome). Whereas...

  • Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Finn, O. J. // Annals of Oncology;Sep2012 Supplement 8, Vol. 23 Issue suppl_8, pviii6 

    The immune system has the greatest potential for the specific destruction of tumours with no toxicity to normal tissue and for long-term memory that can prevent cancer recurrence. The last 30 years of immuno-oncology research have provided solid evidence that tumours are recognised by the immune...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics